ID: h-55bc3e94f8
Hypothesis

C1q effector output is determined more by binding partner identity than by subcellular location

Under this model, C1q is a context decoder whose downstream program depends chiefly on the biochemical identity of the complex it forms, such as neuronal pentraxins, Aβ aggregates, apoptotic membranes, or ECM ligands.
🧬 C1QA,C1QB,C1QC,NPTX1,NPTX2,APP,C3🩺 neurodegeneration🎯 Composite 61%💱 $0.56▼8.6%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 3 support 2 oppose
✓ All Quality Gates Passed
Mechanistic 0.77 (15%) Evidence 0.58 (15%) Novelty 0.73 (12%) Feasibility 0.64 (12%) Impact 0.54 (12%) Druggability 0.39 (10%) Safety 0.56 (8%) Competition 0.69 (6%) Data Avail. 0.61 (5%) Reproducible 0.55 (5%) KG Connect 0.50 (8%) 0.610 composite

🧪 Overview

Under this model, C1q is a context decoder whose downstream program depends chiefly on the biochemical identity of the complex it forms, such as neuronal pentraxins, Aβ aggregates, apoptotic membranes, or ECM ligands. Spatial localization remains relevant, but as a secondary variable relative to ligand chemistry and complex composition.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Target Gene: C1QAC1QBC1QCNPTX1NPTX2APPC3"]
    B["Molecular Mechanism<br/>Pathway Activation"]
    C["Cellular Phenotype<br/>Neuronal / Glial Response"]
    D["Network Effect<br/>Circuit-Level Consequence"]
    E["Disease Relevance<br/>Neurodegeneration Link"]
    A --> B --> C --> D --> E
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style E fill:#1b5e20,stroke:#81c784,color:#81c784

⚖️ Evidence

⚖️ Evidence Matrix3 supports2 contradicts
Supports
C1q binds diverse ligands including Aβ, indicating that binding-partner identity can shape downstream complement activation.
Supports
Aβ-C1q complexes activate complement in AD-relevant settings, supporting ligand-specific effector programs.
Supports
Neuronal pentraxins interact with C1q, providing a plausible synaptic ligand axis distinct from plaque-associated ligands.
Contradicts
No decisive CNS study yet demonstrates that ligand identity explains more variance than location when ligand, receiver cell, and complement competence are independently controlled.
Contradicts
Microenvironmental geometry, local complement regulators, and which cell encounters the complex first may rival or exceed ligand identity in determining outcome.
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — C1QA

🧬 PDB 1PK6 Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for C1QA,C1QB,C1QC,NPTX1,NPTX2,APP,C3 from GTEx v10.

Spinal cord cervical c-174.7 Substantia nigra38.2median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for C1QA,C1QB,C1QC,NPTX1,NPTX2,APP,C3 →

No DepMap CRISPR Chronos data found for C1QA,C1QB,C1QC,NPTX1,NPTX2,APP,C3.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 0.5%
Volatility
Low
0.0027
Events (7d)
2
Price History
▼8.6%

💾 Resource Usage

LLM Tokens
19,754
$0.0593
Total Cost
$0.0593

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF C1q is targeted to neuronal dendrites via cell-impermeant crosslinking versus allowed to diffuse freely in extracellular space while binding identical NPTX2 ligand, THEN the downstream complement CEquivalent C3 deposition regardless of C1q-NPTX2 spatial targeting; opsonization rate difference <15%— no observation —pending0.55
IF C1q is pre-incubated with neuronal pentraxin 1 (NPTX1) to form C1q-NPTX1 complexes versus pre-incubated with amyloid-beta (APP-derived Aβ1-42) to form C1q-Aβ complexes, THEN human iPSC-derived cortDifferential complement gene expression; C1q-Aβ complexes will upregulate C3 and C4B mRNA 2-3 fold higher than C1q-NPTX1 complexes— no observation —pending0.60
🔮 Falsifiable Predictions (2)
pendingconf 60%
IF C1q is pre-incubated with neuronal pentraxin 1 (NPTX1) to form C1q-NPTX1 complexes versus pre-incubated with amyloid-beta (APP-derived Aβ1-42) to form C1q-Aβ complexes, THEN human iPSC-derived cortical neurons will exhibit significantly different transcriptional profiles of complement-related gen
Predicted outcome: Differential complement gene expression; C1q-Aβ complexes will upregulate C3 and C4B mRNA 2-3 fold higher than C1q-NPTX1 complexes
Falsification: If C1q-NPTX1 and C1q-Aβ complexes produce statistically equivalent complement gene expression (difference <1.2-fold, p > 0.05), the hypothesis that binding partner identity is primary would be falsifi
pendingconf 55%
IF C1q is targeted to neuronal dendrites via cell-impermeant crosslinking versus allowed to diffuse freely in extracellular space while binding identical NPTX2 ligand, THEN the downstream complement C3 opsonization rate on hippocampal neurons will remain unchanged (within 15% variance), indicating l
Predicted outcome: Equivalent C3 deposition regardless of C1q-NPTX2 spatial targeting; opsonization rate difference <15%
Falsification: If targeted C1q-NPTX2 produces ≥40% higher C3 deposition than freely-diffused C1q-NPTX2, location would be the primary determinant rather than ligand identity, falsifying this prediction
Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
sourcev1_phase_c_backfill
origin_typedebate_synthesizer
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.